HAI Pathogens and Antimicrobial Resistance Report, 2018-2021

Adult Data Tables

Print
PAGE 5 of 19

‹View Table of Contents

Related Pages

Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type, Adults, 2018-2021

Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type, Adults, 2018-2021
Acute Care Hospitals (n=2,988 hospitals)  
Hospital ICUs Hospital Wards1 Hospital Oncology Units2 LTACHs3
(n=420 hospitals)
Pathogen # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank
Coagulase-negative staphylococci 7,553 17.0 1 4,181 10.9 2 2,380 10.6 2 886 10.7 3
Enterococcus faecalis4 5,539 12.5 2 3,344 8.7 4 970 4.3 8 1,088 13.2 1
Candida albicans4 5,363 12.1 3 2,574 6.7 6 260 1.2 16 451 5.5 7
Other Candida spp.4 3,813 8.6 4 2,287 5.9 7 631 2.8 10 818 9.9 5
Staphylococcus aureus 3,288 7.4 5 5,914 15.4 1 1,307 5.8 6 910 11.0 2
Enterococcus faecium4 3,200 7.2 6 1,884 4.9 8 1,974 8.8 4 487 5.9 6
Candida glabrata4 3,126 7.0 7 1,677 4.4 9 328 1.5 14 343 4.2 9
Select Klebsiella spp. 2,074 4.7 8 3,519 9.1 3 1,824 8.2 5 874 10.6 4
Escherichia coli 1,323 3.0 9 2,601 6.8 5 3,923 17.5 1 335 4.1 10
Pseudomonas aeruginosa 1,316 3.0 10 1,644 4.3 10 1,011 4.5 7 414 5.0 8
Enterobacter spp. 1,037 2.3 11 1,374 3.6 11 741 3.3 9 277 3.4 11
Serratia spp. 834 1.9 12 765 2.0 12 149 0.7 21 191 2.3 13
Other Enterococcus spp.4 735 1.7 13 496 1.3 14 426 1.9 11 91 1.1 16
Yeast, not specified 516 1.2 14 283 0.7 19 10 <0.1 79 138 1.7 15
Acinetobacter spp. 448 1.0 15 473 1.2 16 63 0.3 31 158 1.9 14
Other pathogen 4,321 9.7 5,483 14.2 6,371 28.5 790 9.6
Total 44,486 100.0 38,499 100.0 22,368 100.0 8,251 100.0

Note: Refer to Technical Resources for more information about the acronyms and terms used in this table.

Footnotes:

  1. Some rankings are not shown: Proteus (#13, 1.4%); Viridans group streptococci (#15, 1.3%).
  2. Some rankings are not shown: Viridans group streptococci (#3, 10.2%); Bacteroides (#12, 1.6%); Rothia mucilaginosa (#13, 1.6%); Gemella haemolysans (#15, 1.2%).
  3. Some rankings are not shown: Proteus spp. (#12, 2.4%).
  4. When analyzed at the genus-level, Candida and Enterococcus spp. resulted in the following rankings:
    1. Candida spp. – hospital ICUs (#1, 27.7%); hospital wards (#1, 17.0%); hospital oncology units (#7, 5.4%); LTACHs (#2, 19.5%).
    2. Enterococcus spp. – hospital ICUs (#2, 21.3%); hospital wards (#3, 14.9%); hospital oncology units (#2, 15.1%); LTACHs (#1, 20.2%).

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs
  2. Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table 3. The Top 15 HAI Pathogens Reported to NHSN
  5. ›Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type
  7. Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type
  8. Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  9. Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type
  10. Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  11. Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume
  12. Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type
  13. Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  14. Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status
  15. Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  16. Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type
  17. Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume
  18. Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume
  19. Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type